Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shire Explores Robotic Pill Potential For Hemophilia

Dec 06 2017

• By Kevin Grogan

SC1712_Chalk Arrow_265447892_1200.jpg — New direction: Shire and Rani will explore oral therapies for hemophilia A • Source: Shutterstock

Related Content

Shire Tempts Busch From Bayer As It Eyes Top Spot In Rare Diseases

Dec 01 2017

Rani raises cash for 'holy grail' of oral formulations for biologics

Aug 30 2013

Related Companies

Takeda Pharmaceutical Co. Ltd.

Rani Therapeutics Holdings, Inc.

Baxalta Incorporated

Roche Holding AG

Novartis AG

AstraZeneca PLC

Allergan plc

Additional Topics

Deals Innovation Research & Development Companies Blood & Coagulation Disorders BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.